CBD Life Sciences Inc.
CBDL · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1,366 | $1,549 | $1,031 | $3,850 |
| - Cash | $127 | $7 | -$8 | $18 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,238 | $1,542 | $1,039 | $3,833 |
| Revenue | $16 | $12 | $15 | $39 |
| % Growth | 38% | -23.9% | -61.2% | – |
| Gross Profit | -$13 | $5 | -$11 | $16 |
| % Margin | -78.3% | 39.6% | -71.6% | 40.2% |
| EBITDA | -$19 | -$342 | -$277 | -$49 |
| % Margin | -119.1% | -2,948% | -1,820.1% | -124.9% |
| Net Income | -$38 | -$342 | -$296 | -$67 |
| % Margin | -234.9% | -2,948% | -1,941.8% | -172.1% |
| EPS Diluted | 0 | -0 | -0 | -0 |
| % Growth | 100% | 0% | 0% | – |
| Operating Cash Flow | $46 | – | -$258 | – |
| Capital Expenditures | $0 | – | -$0 | – |
| Free Cash Flow | $46 | – | -$258 | – |